Table of Content

1 Remicade Biosimilar Market Overview
1.1 Remicade Biosimilar Product Overview
1.2 Remicade Biosimilar Market Segment by Type
1.2.1 100mg/10ml
1.2.2 500mg/50ml
1.3 Global Remicade Biosimilar Market Size by Type
1.3.1 Global Remicade Biosimilar Market Size Overview by Type (2018-2029)
1.3.2 Global Remicade Biosimilar Historic Market Size Review by Type (2018-2024)
1.3.3 Global Remicade Biosimilar Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Remicade Biosimilar Sales Breakdown by Type (2018-2024)
1.4.2 Europe Remicade Biosimilar Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Remicade Biosimilar Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Remicade Biosimilar Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Remicade Biosimilar Sales Breakdown by Type (2018-2024)
2 Global Remicade Biosimilar Market Competition by Company
2.1 Global Top Players by Remicade Biosimilar Sales (2018-2024)
2.2 Global Top Players by Remicade Biosimilar Revenue (2018-2024)
2.3 Global Top Players by Remicade Biosimilar Price (2018-2024)
2.4 Global Top Manufacturers Remicade Biosimilar Manufacturing Base Distribution, Sales Area, Product Type
2.5 Remicade Biosimilar Market Competitive Situation and Trends
2.5.1 Remicade Biosimilar Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Remicade Biosimilar Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Remicade Biosimilar as of 2022)
2.7 Date of Key Manufacturers Enter into Remicade Biosimilar Market
2.8 Key Manufacturers Remicade Biosimilar Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Remicade Biosimilar Status and Outlook by Region
3.1 Global Remicade Biosimilar Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Remicade Biosimilar Historic Market Size by Region
3.2.1 Global Remicade Biosimilar Sales in Volume by Region (2018-2024)
3.2.2 Global Remicade Biosimilar Sales in Value by Region (2018-2024)
3.2.3 Global Remicade Biosimilar Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Remicade Biosimilar Forecasted Market Size by Region
3.3.1 Global Remicade Biosimilar Sales in Volume by Region (2024-2029)
3.3.2 Global Remicade Biosimilar Sales in Value by Region (2024-2029)
3.3.3 Global Remicade Biosimilar Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Remicade Biosimilar by Application
4.1 Remicade Biosimilar Market Segment by Application
4.1.1 Blood Disorders
4.1.2 Oncology Diseases
4.2 Global Remicade Biosimilar Market Size by Application
4.2.1 Global Remicade Biosimilar Market Size Overview by Application (2018-2029)
4.2.2 Global Remicade Biosimilar Historic Market Size Review by Application (2018-2024)
4.2.3 Global Remicade Biosimilar Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Remicade Biosimilar Sales Breakdown by Application (2018-2024)
4.3.2 Europe Remicade Biosimilar Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Remicade Biosimilar Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Remicade Biosimilar Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Remicade Biosimilar Sales Breakdown by Application (2018-2024)
5 North America Remicade Biosimilar by Country
5.1 North America Remicade Biosimilar Historic Market Size by Country
5.1.1 North America Remicade Biosimilar Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Remicade Biosimilar Sales in Volume by Country (2018-2024)
5.1.3 North America Remicade Biosimilar Sales in Value by Country (2018-2024)
5.2 North America Remicade Biosimilar Forecasted Market Size by Country
5.2.1 North America Remicade Biosimilar Sales in Volume by Country (2024-2029)
5.2.2 North America Remicade Biosimilar Sales in Value by Country (2024-2029)
6 Europe Remicade Biosimilar by Country
6.1 Europe Remicade Biosimilar Historic Market Size by Country
6.1.1 Europe Remicade Biosimilar Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Remicade Biosimilar Sales in Volume by Country (2018-2024)
6.1.3 Europe Remicade Biosimilar Sales in Value by Country (2018-2024)
6.2 Europe Remicade Biosimilar Forecasted Market Size by Country
6.2.1 Europe Remicade Biosimilar Sales in Volume by Country (2024-2029)
6.2.2 Europe Remicade Biosimilar Sales in Value by Country (2024-2029)
7 Asia-Pacific Remicade Biosimilar by Region
7.1 Asia-Pacific Remicade Biosimilar Historic Market Size by Region
7.1.1 Asia-Pacific Remicade Biosimilar Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Remicade Biosimilar Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Remicade Biosimilar Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Remicade Biosimilar Forecasted Market Size by Region
7.2.1 Asia-Pacific Remicade Biosimilar Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Remicade Biosimilar Sales in Value by Region (2024-2029)
8 Latin America Remicade Biosimilar by Country
8.1 Latin America Remicade Biosimilar Historic Market Size by Country
8.1.1 Latin America Remicade Biosimilar Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Remicade Biosimilar Sales in Volume by Country (2018-2024)
8.1.3 Latin America Remicade Biosimilar Sales in Value by Country (2018-2024)
8.2 Latin America Remicade Biosimilar Forecasted Market Size by Country
8.2.1 Latin America Remicade Biosimilar Sales in Volume by Country (2024-2029)
8.2.2 Latin America Remicade Biosimilar Sales in Value by Country (2024-2029)
9 Middle East and Africa Remicade Biosimilar by Country
9.1 Middle East and Africa Remicade Biosimilar Historic Market Size by Country
9.1.1 Middle East and Africa Remicade Biosimilar Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Remicade Biosimilar Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Remicade Biosimilar Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Remicade Biosimilar Forecasted Market Size by Country
9.2.1 Middle East and Africa Remicade Biosimilar Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Remicade Biosimilar Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Synthon Pharmaceuticals
10.1.1 Synthon Pharmaceuticals Company Information
10.1.2 Synthon Pharmaceuticals Introduction and Business Overview
10.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Synthon Pharmaceuticals Remicade Biosimilar Products Offered
10.1.5 Synthon Pharmaceuticals Recent Development
10.2 LG Life Sciences
10.2.1 LG Life Sciences Company Information
10.2.2 LG Life Sciences Introduction and Business Overview
10.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.2.4 LG Life Sciences Remicade Biosimilar Products Offered
10.2.5 LG Life Sciences Recent Development
10.3 Novartis (Sandoz)
10.3.1 Novartis (Sandoz) Company Information
10.3.2 Novartis (Sandoz) Introduction and Business Overview
10.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novartis (Sandoz) Remicade Biosimilar Products Offered
10.3.5 Novartis (Sandoz) Recent Development
10.4 Celltrion
10.4.1 Celltrion Company Information
10.4.2 Celltrion Introduction and Business Overview
10.4.3 Celltrion Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Celltrion Remicade Biosimilar Products Offered
10.4.5 Celltrion Recent Development
10.5 Biocon
10.5.1 Biocon Company Information
10.5.2 Biocon Introduction and Business Overview
10.5.3 Biocon Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Biocon Remicade Biosimilar Products Offered
10.5.5 Biocon Recent Development
10.6 Hospira
10.6.1 Hospira Company Information
10.6.2 Hospira Introduction and Business Overview
10.6.3 Hospira Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Hospira Remicade Biosimilar Products Offered
10.6.5 Hospira Recent Development
10.7 Merck Serono (Merck Group)
10.7.1 Merck Serono (Merck Group) Company Information
10.7.2 Merck Serono (Merck Group) Introduction and Business Overview
10.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merck Serono (Merck Group) Remicade Biosimilar Products Offered
10.7.5 Merck Serono (Merck Group) Recent Development
10.8 Biogen idec Inc.
10.8.1 Biogen idec Inc. Company Information
10.8.2 Biogen idec Inc. Introduction and Business Overview
10.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Biogen idec Inc. Remicade Biosimilar Products Offered
10.8.5 Biogen idec Inc. Recent Development
10.9 Genentech (Roche Group)
10.9.1 Genentech (Roche Group) Company Information
10.9.2 Genentech (Roche Group) Introduction and Business Overview
10.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Genentech (Roche Group) Remicade Biosimilar Products Offered
10.9.5 Genentech (Roche Group) Recent Development
10.10 Fosun Pharmaceutical
10.10.1 Fosun Pharmaceutical Company Information
10.10.2 Fosun Pharmaceutical Introduction and Business Overview
10.10.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Fosun Pharmaceutical Remicade Biosimilar Products Offered
10.10.5 Fosun Pharmaceutical Recent Development
10.11 Livzon Pharmaceutical
10.11.1 Livzon Pharmaceutical Company Information
10.11.2 Livzon Pharmaceutical Introduction and Business Overview
10.11.3 Livzon Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Livzon Pharmaceutical Remicade Biosimilar Products Offered
10.11.5 Livzon Pharmaceutical Recent Development
10.12 Anke Biotechnology
10.12.1 Anke Biotechnology Company Information
10.12.2 Anke Biotechnology Introduction and Business Overview
10.12.3 Anke Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Anke Biotechnology Remicade Biosimilar Products Offered
10.12.5 Anke Biotechnology Recent Development
10.13 Hualan Biological Engineering
10.13.1 Hualan Biological Engineering Company Information
10.13.2 Hualan Biological Engineering Introduction and Business Overview
10.13.3 Hualan Biological Engineering Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Hualan Biological Engineering Remicade Biosimilar Products Offered
10.13.5 Hualan Biological Engineering Recent Development
10.14 Walvax Biotechnology
10.14.1 Walvax Biotechnology Company Information
10.14.2 Walvax Biotechnology Introduction and Business Overview
10.14.3 Walvax Biotechnology Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Walvax Biotechnology Remicade Biosimilar Products Offered
10.14.5 Walvax Biotechnology Recent Development
10.15 Hisun Pharmaceutical
10.15.1 Hisun Pharmaceutical Company Information
10.15.2 Hisun Pharmaceutical Introduction and Business Overview
10.15.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Hisun Pharmaceutical Remicade Biosimilar Products Offered
10.15.5 Hisun Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Remicade Biosimilar Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Remicade Biosimilar Industrial Chain Analysis
11.4 Remicade Biosimilar Market Dynamics
11.4.1 Remicade Biosimilar Industry Trends
11.4.2 Remicade Biosimilar Market Drivers
11.4.3 Remicade Biosimilar Market Challenges
11.4.4 Remicade Biosimilar Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Remicade Biosimilar Distributors
12.3 Remicade Biosimilar Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 100mg/10ml
Table 2. Major Company of 500mg/50ml
Table 3. Global Remicade Biosimilar Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Remicade Biosimilar Sales by Type (2018-2024) & (L)
Table 5. Global Remicade Biosimilar Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Remicade Biosimilar Sales by Type (2018-2024) & (US& Million)
Table 7. Global Remicade Biosimilar Market Share in Value by Type (2018-2024)
Table 8. Global Remicade Biosimilar Price by Type (2018-2024) & (US$/Ml)
Table 9. Global Remicade Biosimilar Sales by Type (2024-2029) & (L)
Table 10. Global Remicade Biosimilar Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Remicade Biosimilar Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Remicade Biosimilar Sales Market Share in Value by Type (2024-2029)
Table 13. Global Remicade Biosimilar Price by Type (2024-2029) & (US$/Ml)
Table 14. North America Remicade Biosimilar Sales by Type (2018-2024) & (L)
Table 15. North America Remicade Biosimilar Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Remicade Biosimilar Sales (L) by Type (2018-2024)
Table 17. Europe Remicade Biosimilar Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Remicade Biosimilar Sales (L) by Type (2018-2024)
Table 19. Asia-Pacific Remicade Biosimilar Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Remicade Biosimilar Sales (L) by Type (2018-2024)
Table 21. Latin America Remicade Biosimilar Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Remicade Biosimilar Sales (L) by Type (2018-2024)
Table 23. Middle East and Africa Remicade Biosimilar Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Remicade Biosimilar Sales by Company (2018-2024) & (L)
Table 25. Global Remicade Biosimilar Sales Share by Company (2018-2024)
Table 26. Global Remicade Biosimilar Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Remicade Biosimilar Revenue Share by Company (2018-2024)
Table 28. Global Market Remicade Biosimilar Price by Company (2018-2024) & (US$/Ml)
Table 29. Global Remicade Biosimilar Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Remicade Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Remicade Biosimilar as of 2022)
Table 32. Date of Key Manufacturers Enter into Remicade Biosimilar Market
Table 33. Key Manufacturers Remicade Biosimilar Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Remicade Biosimilar Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Remicade Biosimilar Sales by Region (2018-2024) & (L)
Table 37. Global Remicade Biosimilar Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Remicade Biosimilar Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Remicade Biosimilar Sales Market Share in Value by Region (2018-2024)
Table 40. Global Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2018-2024)
Table 41. Global Remicade Biosimilar Sales by Region (2024-2029) & (L)
Table 42. Global Remicade Biosimilar Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Remicade Biosimilar Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Remicade Biosimilar Sales Market Share in Value by Region (2024-2029)
Table 45. Global Remicade Biosimilar Sales (L), Revenue (US$ Million), Price (US$/Ml) and Gross Margin (2024-2029)
Table 46. Global Remicade Biosimilar Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Remicade Biosimilar Sales by Application (2018-2024) & (L)
Table 48. Global Remicade Biosimilar Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Remicade Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Remicade Biosimilar Sales Market Share in Value by Application (2018-2024)
Table 51. Global Remicade Biosimilar Price by Application (2018-2024) & (US$/Ml)
Table 52. Global Remicade Biosimilar Sales by Application (2024-2029) & (L)
Table 53. Global Remicade Biosimilar Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Remicade Biosimilar Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Remicade Biosimilar Sales Market Share in Value by Application (2024-2029)
Table 56. Global Remicade Biosimilar Price by Application (2024-2029) & (US$/Ml)
Table 57. North America Remicade Biosimilar Sales by Application (2018-2024) (L)
Table 58. North America Remicade Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Remicade Biosimilar Sales by Application (2018-2024) (L)
Table 60. Europe Remicade Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Remicade Biosimilar Sales by Application (2018-2024) (L)
Table 62. Asia-Pacific Remicade Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Remicade Biosimilar Sales by Application (2018-2024) (L)
Table 64. Latin America Remicade Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Remicade Biosimilar Sales by Application (2018-2024) (L)
Table 66. Middle East and Africa Remicade Biosimilar Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Remicade Biosimilar Sales by Country (2018-2024) & (L)
Table 68. North America Remicade Biosimilar Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Remicade Biosimilar Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Remicade Biosimilar Sales Market Share in Value by Country (2018-2024)
Table 71. North America Remicade Biosimilar Sales by Country (2024-2029) & (L)
Table 72. North America Remicade Biosimilar Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Remicade Biosimilar Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Remicade Biosimilar Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Remicade Biosimilar Sales by Country (2018-2024) & (L)
Table 76. Europe Remicade Biosimilar Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Remicade Biosimilar Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Remicade Biosimilar Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Remicade Biosimilar Sales by Country (2024-2029) & (L)
Table 80. Europe Remicade Biosimilar Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Remicade Biosimilar Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Remicade Biosimilar Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Remicade Biosimilar Sales by Region (2018-2024) & (L)
Table 84. Asia-Pacific Remicade Biosimilar Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Remicade Biosimilar Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Remicade Biosimilar Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Remicade Biosimilar Sales by Region (2024-2029) & (L)
Table 88. Asia-Pacific Remicade Biosimilar Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Remicade Biosimilar Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Remicade Biosimilar Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Remicade Biosimilar Sales by Country (2018-2024) & (L)
Table 92. Latin America Remicade Biosimilar Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Remicade Biosimilar Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Remicade Biosimilar Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Remicade Biosimilar Sales by Country (2024-2029) & (L)
Table 96. Latin America Remicade Biosimilar Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Remicade Biosimilar Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Remicade Biosimilar Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Remicade Biosimilar Sales by Country (2018-2024) & (L)
Table 100. Middle East and Africa Remicade Biosimilar Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Remicade Biosimilar Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Remicade Biosimilar Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Remicade Biosimilar Sales by Country (2024-2029) & (L)
Table 104. Middle East and Africa Remicade Biosimilar Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Remicade Biosimilar Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Remicade Biosimilar Sales Market Share in Value by Country (2024-2029)
Table 107. Synthon Pharmaceuticals Company Information
Table 108. Synthon Pharmaceuticals Introduction and Business Overview
Table 109. Synthon Pharmaceuticals Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 110. Synthon Pharmaceuticals Remicade Biosimilar Product
Table 111. Synthon Pharmaceuticals Recent Development
Table 112. LG Life Sciences Company Information
Table 113. LG Life Sciences Introduction and Business Overview
Table 114. LG Life Sciences Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 115. LG Life Sciences Remicade Biosimilar Product
Table 116. LG Life Sciences Recent Development
Table 117. Novartis (Sandoz) Company Information
Table 118. Novartis (Sandoz) Introduction and Business Overview
Table 119. Novartis (Sandoz) Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 120. Novartis (Sandoz) Remicade Biosimilar Product
Table 121. Novartis (Sandoz) Recent Development
Table 122. Celltrion Company Information
Table 123. Celltrion Introduction and Business Overview
Table 124. Celltrion Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 125. Celltrion Remicade Biosimilar Product
Table 126. Celltrion Recent Development
Table 127. Biocon Company Information
Table 128. Biocon Introduction and Business Overview
Table 129. Biocon Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 130. Biocon Remicade Biosimilar Product
Table 131. Biocon Recent Development
Table 132. Hospira Company Information
Table 133. Hospira Introduction and Business Overview
Table 134. Hospira Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 135. Hospira Remicade Biosimilar Product
Table 136. Hospira Recent Development
Table 137. Merck Serono (Merck Group) Company Information
Table 138. Merck Serono (Merck Group) Introduction and Business Overview
Table 139. Merck Serono (Merck Group) Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 140. Merck Serono (Merck Group) Remicade Biosimilar Product
Table 141. Merck Serono (Merck Group) Recent Development
Table 142. Biogen idec Inc. Company Information
Table 143. Biogen idec Inc. Introduction and Business Overview
Table 144. Biogen idec Inc. Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 145. Biogen idec Inc. Remicade Biosimilar Product
Table 146. Biogen idec Inc. Recent Development
Table 147. Genentech (Roche Group) Company Information
Table 148. Genentech (Roche Group) Introduction and Business Overview
Table 149. Genentech (Roche Group) Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 150. Genentech (Roche Group) Remicade Biosimilar Product
Table 151. Genentech (Roche Group) Recent Development
Table 152. Fosun Pharmaceutical Company Information
Table 153. Fosun Pharmaceutical Introduction and Business Overview
Table 154. Fosun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 155. Fosun Pharmaceutical Remicade Biosimilar Product
Table 156. Fosun Pharmaceutical Recent Development
Table 157. Livzon Pharmaceutical Company Information
Table 158. Livzon Pharmaceutical Introduction and Business Overview
Table 159. Livzon Pharmaceutical Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 160. Livzon Pharmaceutical Remicade Biosimilar Product
Table 161. Livzon Pharmaceutical Recent Development
Table 162. Anke Biotechnology Company Information
Table 163. Anke Biotechnology Introduction and Business Overview
Table 164. Anke Biotechnology Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 165. Anke Biotechnology Remicade Biosimilar Product
Table 166. Anke Biotechnology Recent Development
Table 167. Hualan Biological Engineering Company Information
Table 168. Hualan Biological Engineering Introduction and Business Overview
Table 169. Hualan Biological Engineering Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 170. Hualan Biological Engineering Remicade Biosimilar Product
Table 171. Hualan Biological Engineering Recent Development
Table 172. Walvax Biotechnology Company Information
Table 173. Walvax Biotechnology Introduction and Business Overview
Table 174. Walvax Biotechnology Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 175. Walvax Biotechnology Remicade Biosimilar Product
Table 176. Walvax Biotechnology Recent Development
Table 177. Hisun Pharmaceutical Company Information
Table 178. Hisun Pharmaceutical Introduction and Business Overview
Table 179. Hisun Pharmaceutical Remicade Biosimilar Sales (L), Revenue (Million USD), Price (US$/Ml) and Gross Margin (2018-2024)
Table 180. Hisun Pharmaceutical Remicade Biosimilar Product
Table 181. Hisun Pharmaceutical Recent Development
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Remicade Biosimilar Market Trends
Table 185. Remicade Biosimilar Market Drivers
Table 186. Remicade Biosimilar Market Challenges
Table 187. Remicade Biosimilar Market Restraints
Table 188. Remicade Biosimilar Distributors List
Table 189. Remicade Biosimilar Downstream Customers
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Remicade Biosimilar Product Picture
Figure 2. Global Remicade Biosimilar Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Remicade Biosimilar Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Remicade Biosimilar Sales Status and Outlook (2018-2029) & (L)
Figure 5. Product Picture of 100mg/10ml
Figure 6. Global 100mg/10ml Sales YoY Growth (2018-2029) & (L)
Figure 7. Product Picture of 500mg/50ml
Figure 8. Global 500mg/50ml Sales YoY Growth (2018-2029) & (L)
Figure 9. Global Remicade Biosimilar Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Remicade Biosimilar Sales Market Share by Type in 2022 & 2029
Figure 11. North America Remicade Biosimilar Sales Market Share in Volume by Type in 2022
Figure 12. North America Remicade Biosimilar Sales Market Share in Value by Type in 2022
Figure 13. Europe Remicade Biosimilar Sales Market Share in Volume by Type in 2022
Figure 14. Europe Remicade Biosimilar Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Remicade Biosimilar Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Remicade Biosimilar Sales Market Share in Value by Type in 2022
Figure 17. Latin America Remicade Biosimilar Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Remicade Biosimilar Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Remicade Biosimilar Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Remicade Biosimilar Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Remicade Biosimilar Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Remicade Biosimilar Revenue in 2022
Figure 23. Remicade Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Blood Disorders
Figure 25. Global Blood Disorders Sales YoY Growth (2018-2029) & (L)
Figure 26. Product Picture of Oncology Diseases
Figure 27. Global Oncology Diseases Sales YoY Growth (2018-2029) & (L)
Figure 28. Global Remicade Biosimilar Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Remicade Biosimilar Sales Market Share by Application in 2022 & 2029
Figure 30. North America Remicade Biosimilar Sales Market Share in Volume by Application in 2022
Figure 31. North America Remicade Biosimilar Sales Market Share in Value by Application in 2022
Figure 32. Europe Remicade Biosimilar Sales Market Share in Volume by Application in 2022
Figure 33. Europe Remicade Biosimilar Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Remicade Biosimilar Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Remicade Biosimilar Sales Market Share in Value by Application in 2022
Figure 36. Latin America Remicade Biosimilar Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Remicade Biosimilar Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Remicade Biosimilar Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Remicade Biosimilar Manufacturing Cost Structure
Figure 41. Remicade Biosimilar Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed